4 results match your criteria: "The First Attached Hospital of Shaoyang University[Affiliation]"
Ann Med
December 2023
Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) document suggests that patients with chronic obstructive pulmonary disease (COPD) should be divided into a less symptomatic group. Moreover, single-inhaled drugs are recommended as initial inhalation therapy for them. However, many less symptomatic patients are provided double or triple-inhaled drugs as initial therapy in the real world.
View Article and Find Full Text PDFLibyan J Med
December 2022
Department of Respiratory and Critical Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Immun Inflamm Dis
February 2022
Department of Respiratory Medicine, The First Attached Hospital of Shaoyang University, Shaoyang, Hunan, China.
Background: Coronavirus disease (COVID-19) is a global infectious disease with a large burden of illness and high health care costs. This study aimed to compare clinical features among adult COVID-19 patients in different age groups.
Methods: Laboratory-confirmed adult COVID-19 infection cases between December 31, 2019 to March 8, 2020 obtained from Neighboring Cities.
Int J Gen Med
September 2021
Department of Respiratory and Critical Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Background: Oxygen therapy (OT) is the most widely used supportive regime in patients with hypoxemic acute respiratory failure (ARF) due to severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. The aim of this study was to identify the effect of noninvasive ventilation support on coronavirus disease 2019 (COVID-19) patients and risk factors for invasive mechanical ventilation (IMV).
Methods: We retrospectively analyzed confirmed COVID-19 subjects from nine hospitals outside Wuhan.